URUrology Research3083-49102981-8230Bio-Byword Scientific Publishing Pty. Ltd.10.26689/ur.v2i4.9318ArticleEfficacy of Yishen Tongluo Formula Combined with Sulodexide in the Treatment of Diabetic Nephropathy with Renal Failurehttps://artdesignp.com/journal/UR/2/4/10.26689/ur.v2i4.9318LiLin,LiChenchen,ZhangLimin,JiJuan,GaoYan,QinWei2025242025-01-08Objective: To analyze the effect of Yishen Tongluo Formula combined with sulodexide in treating patients with diabetic nephropathy and renal failure. Methods: A hundred patients with diabetic nephropathy accompanied by renal failure who were admitted to the hospital for treatment from March 2021 to March 2024 were randomly divided into the control group and the observation group, and were treated with sulodexide therapy and Yishen Tongluo Formula + sulodexide therapy, respectively. The treatment efficacy of the two groups was evaluated. Results: After treatment, fasting blood glucose and other levels were lower in the observation group, P < 0.05; renal function indexes in the observation group improved, where levels of 24-hour urinary protein, blood urea nitrogen, and blood creatinine were significantly lower than those of the pre-treatment and control group; the effect of microinflammatory state relief was significant, as demonstrated by the significant decrease of interleukin-6 and other indexes, P < 0.05. Conclusion: In the treatment of diabetic nephropathy patients with renal failure, we should pay attention to the protection of renal function, applying sulodexide to improve patients’ blood glucose indexes, and at the same time, utilizing Yishen Tongluo Formula to alleviate patients’ microinflammatory state and enhance the recovery of renal function.

Bu H, Guo L, Xu K, et al., 2024, A Randomized Controlled Clinical Trial of the Renoprotective Effect of Sulodexide Combined with Valsartan in Patients with Type 2 Diabetic Nephropathy. Journal of Zhengzhou University (Medical Edition), 59(02): 260–265.

Zhang M, Zhang W, Wang A, et al., 2023, Study on the Improvement Effect and Safety of Sulodexide on Multiple Urinary Proteins in Patients with Diabetic Nephropathy. China Medical Engineering, 31(02): 1–5.

Ge J, Fan WX, Ma JY, 2022, Meta-Analysis of the Clinical Efficacy and Safety of Sulodexide Combined with ACEI/ARB Drugs in the Treatment of Diabetic Nephropathy. Chinese Journal of Integrative Nephrology, 23(12): 1082–1087.

Wang J, Ji X, Ji Y, et al., 2022, Efficacy of Yishen Tongluo Formula in the Treatment of Diabetic Nephropathy and its Effects on Glucose Metabolism, Renal Function and Oxidative Stress. Sichuan Traditional Chinese Medicine, 40(11): 126–129.

Dai L, Lin D, 2022, Clinical Analysis of Sulodexide Combined with Tretinoin in the Treatment of Diabetic Nephropathy. Chinese and Foreign Medical Treatment, 41(29): 110–113.

Zhang M, Wang A, Li P, et al., 2022, Effect of Sulodexide on Foot Cell Injury in Patients with Diabetic Nephropathy. Journal of Xinxiang Medical College, 39(03): 248–251.

Ji X, Wang J, Zhang J, 2021, Therapeutic Efficacy of Yishen Tongluo Formula in Treating Vein Stasis Type Diabetic Nephropathy and its Effect on Liver and Kidney Function and CCr. Sichuan Traditional Chinese Medicine, 39(11): 146–149.

Gao X, Wang Y, 2020, Effects of Bailing Capsule Combined with Sulodexide on Vascular Endothelial Function and Oxidative Stress Function Indexes in Elderly Patients with Diabetic Nephropathy. Drug Evaluation Research, 43(09): 1864–1867.

Guo S, Ma L, 2019, Clinical Efficacy Study of Yishen Tongluo Formula in the Treatment of Diabetic Nephropathy Stage III. Xinjiang Traditional Chinese Medicine, 37(05): 5–8.

Zhao H, Zhao Q, Jiao Y, et al., 2018, Efficacy of Sulodexide Combined with Repaglinide in the Treatment of Diabetic Nephropathy and its Effect on Serum Inflammatory Factor Levels. China Hospital Drug Evaluation and Analysis, 18(07): 898–900.